Xu, Ming http://orcid.org/0000-0002-4477-939X
Pirtskhalava, Tamar
Farr, Joshua N.
Weigand, Bettina M.
Palmer, Allyson K. http://orcid.org/0000-0001-7505-3455
Weivoda, Megan M.
Inman, Christina L.
Ogrodnik, Mikolaj B.
Hachfeld, Christine M.
Fraser, Daniel G.
Onken, Jennifer L.
Johnson, Kurt O.
Verzosa, Grace C.
Langhi, Larissa G. P.
Weigl, Moritz
Giorgadze, Nino
LeBrasseur, Nathan K.
Miller, Jordan D.
Jurk, Diana
Singh, Ravinder J.
Allison, David B. http://orcid.org/0000-0003-3566-9399
Ejima, Keisuke http://orcid.org/0000-0002-1185-3987
Hubbard, Gene B.
Ikeno, Yuji
Cubro, Hajrunisa
Garovic, Vesna D.
Hou, Xiaonan
Weroha, S. John
Robbins, Paul D.
Niedernhofer, Laura J.
Khosla, Sundeep http://orcid.org/0000-0002-2936-4372
Tchkonia, Tamara
Kirkland, James L.
Article History
Received: 11 October 2017
Accepted: 9 May 2018
First Online: 9 July 2018
Competing interests
: J.L.K, T.T., M.X., T.P., N.G., and A.K.P. have a financial interest related to this research. Patents on senolytic drugs (PCT/US2016/041646, filed at the US Patent Office) are held by Mayo Clinic. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and was conducted in compliance with Mayo Clinic Conflict of Interest policies. None of the other authors has a relevant financial conflict of interest.